Tahseen Alam

Dr. Tahseen Alam

National University of Sciences and Technology, Pakistan
+1
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 September 2020 in Nanomaterials
Verified
Journal Article
Open access
PDF file
SRSUNDUS RIAZ
SUNDUS RIAZ
NRNosheen Fatima Rana
Nosheen Fatima Rana
Irshad HussianIrshad Hussian
Irshad Hussian
TTTahreem Tanweer
Tahreem Tanweer
ANAfrah Nawaz
Afrah Nawaz
SASyed Mohsin Ali
Syed Mohsin Ali
Multidrug resistance (MDR) has been a potentiator for the exploration of antibiotics. Nano drug delivery systems have opened new avenues to overcome this challenge. Although antibacterial nanocarriers are extensively realized, their effect on the bacteria residing inside the tissues and their toxicity is rarely explored. This study investigated the effects of flavonoid coated gold nanoparticles (FAuNPs) on the colonization of Enterococcus faecalis in the mouse liver and kidneys. Flavonoids were extracted from the leaves of Berberis lycium Royle and used to stabilize gold following a green synthesis approach. FAuNPs were characterized by ultraviolet-visible (UV-Vis) spectroscopy, Fourier-transform infrared spectroscopy (FTIR), scanning transmission electron microscopy (STEM), X-ray powder diffraction (XRD), and energy-dispersive X-ray spectroscopy (EDS). FAuNPs showed significantly higher reduction in bacterial counts in in-vitro and in-vivo in mice organs as compared to the free flavonoids owing to their biocompatibility and effectiveness.

1 September 2017 in Colloids and Surfaces A: Physicochemical and Engineering Aspects
Verified
Journal Article
Closed access
UHUzair Hashmi
Uzair Hashmi
FKFaria Khan
Faria Khan
DKDr Nauman Khalid
Dr Nauman Khalid
ASAsad Abdullah Shahid
Asad Abdullah Shahid
AJAqib Javed
Aqib Javed
HJHussnain Ahmed Janjua
Hussnain Ahmed Janjua

2 July 2020 in Journal of Food Biochemistry
Verified
Journal Article
Closed access
PDF file
SNSadia Nazir
Sadia Nazir
RFRai Khalid Farooq
Rai Khalid Farooq
HKHina Khan
Hina Khan
TATahseen Alam
Tahseen Alam
AJAneela Javed
Aneela Javed
Global health estimates indicated approximately 322 million people living with depression. Rising cost of depressive illness treatment and non‐responsiveness to existing therapies demand continued research to explore new and more potent therapies. Exploring the potential of natural compounds for their potent antidepressant potentials is becoming topic of interest for scientists. Anti‐inflammatory activity of thymoquinone, the active ingredient of Nigella sativa , has been well documented. Current study tested thymoquinone for its antidepressant effect in a Concanavalin A (Con A)‐induced depressive‐like behavior in BALB/c mice. Thymoquinone successfully protected against Con A‐induced behavioral despair and anxiety‐like behavior. Reduced grooming behavior as a function of Con A treatment, was also reinstated. Underlying mechanism responsible for antidepressant activity of thymoquinone was analyzed by molecular docking. Thymoquinone interacts in halogen‐binding pocket (HBP) of serotonin reuptake transporter indicating its potential as serotonin reuptake inhibitor. Results of current study anticipate thymoquinone as a potential antidepressant drug candidate. Practical applications Black seeds of Nigella sativa are consumed with traditional and religious reference since centuries. Thymoquinone, active, and abundant component of Nigella sativa , has shown positive effects in multiple studies against arthritis, asthma, hepatic injury, neurodegeneration, and cancer owing to its immunomodulatory and anti‐inflammatory attributes. Considering inflammation as one of central components involved in pathophysiology of major depressive disorder, thymoquinone has been evaluated in current study for its antidepressant potential. Positive results of current study propose thymoquinone as an affordable, natural antidepressant drug candidate with better safety profile than currently available antidepressant regimes. Thymoquinone might provide benefits against inflammation‐related sickness behavior that is associated with poorer outcome of clinical depression, thus, paving the way for effective drug development against treatment‐resistant depression.

1 December 2019 in Colloids and Surfaces B: Biointerfaces
Verified
Journal Article
Closed access
UHUzair Hashmi
Uzair Hashmi
DKDr Nauman Khalid
Dr Nauman Khalid
TATahseen Alam
Tahseen Alam
RHRumeza Hanif
Rumeza Hanif
HJHussnain Janjua
Hussnain Janjua